Plus: effect of wireless MagSafe tech on medical devices; more
Tuesday, June 15, 2021 : Issue #1141 |
|
Letter from the Editor
Before Amylin hit it big with Byetta and Bydureon, and their employees and stock holders were well rewarded with their eventual purchase by BMS and AZ, they had another product that many of us thought would be a big hit. You may remember a product called SYMLIN® (pramlintide acetate) that is an analog of the pancreatic hormone amylin that the company took their name from.
This drug looked to be a great product for both type 1 and type 2 patients, and had some of the same great qualities found in the GLP-1 analog class, but it needed multiple daily injections and it never really caught on with the type 1 crowd. As the success of the GLP-’s grew the use of pramlintide almost disappeared.
This week our intern, George McConnell, PharmD. Candidate, LECOM School of Pharmacy, takes a look at a possible new way to deliver pramlintide, and how valuable it can be for type 1 patients, especially if they are on a closed loop system.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief |
|
| |
|
|
|
Newsflash: Evidence Builds for iPhone 12 Pro Max Interference with Cardiac Devices
With magnet strength in wireless charging technology going up, it poses a problem for heart devices. AHA June 2, 2021 |
TOP STORIES - Diabetes News and Research |
|
| |
|
|
|
| | | | About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control. |
| Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
www.diabetesincontrol.com |
|
|
|
|
| | |
|
|
|
|
